Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Drug Metabolism And Disposition

• Publication date

  2001-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11159795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interindividual variability of coumarin 7-hydroxylation in a Turkish population

  2004cited by this paper
• Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.

  2001cited by this paper
• CYP2A6: a human coumarin 7-hydroxylase.

  2000cited by this paper
• CYP2A6 genotype and smoking

  2000cited by this paper
• CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians

  2000influential reference
• Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

  2000cited by this paper
• Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

  2000cited by this paper
• Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.

  2000cited by this paper
• Genetic variation of CYP2A6, smoking, and risk of cancer.

  1999cited by this paper
• Genetic variation of CYP2A6, smoking, and risk of cancer

  1999cited by this paper
• Ethnic differences in N-glucuronidation of nicotine and cotinine.

  1999cited by this paper
• Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population

  1999cited by this paper
• Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism

  1999cited by this paper
• Biotransformation of coumarin by rodent and human cytochromes P-450: metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice.

  1999cited by this paper
• Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype.

  1999cited by this paper
• CYP2A6 gene deletion reduces susceptibility to lung cancer.

  1999influential reference
• Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism.

  1999cited by this paper
• Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes

  1999cited by this paper
• Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.

  1999cited by this paper
• Expression of CYP2A genes in human liver and extrahepatic tissues.

  1999cited by this paper
• The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP.

  1999cited by this paper
• Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method.

  1999cited by this paper
• An Improved Assay Shows No Association Between the CYP2A6 Gene and Cigarette Smoking Behavior

  1999cited by this paper
• Nicotine metabolism defect reduces smoking

  1998cited by this paper
• A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).

  1998cited by this paper
• Genetic influences on smoking: candidate genes.

  1998cited by this paper
• Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6

  1998cited by this paper
• Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase

  1998cited by this paper
• Individual differences in nicotine kinetics and metabolism in humans.

  1997cited by this paper
• Environment and cancer: who are susceptible?

  1997cited by this paper
• A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes.

  1997cited by this paper
• A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.

  1997cited by this paper
• Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.

  1997cited by this paper
• Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations.

  1996cited by this paper
• Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.

  1996cited by this paper
• CYP2D6 phenotype and the metabolism of nicotine and cotinine.

  1996cited by this paper
• Role of human cytochrome P4502A6 in C-oxidation of nicotine.

  1996cited by this paper
• Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19

  1995cited by this paper
• Expression and alternative splicing of the cytochrome P-450 CYP2A7.

  1995cited by this paper
• CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.

  1995cited by this paper
• A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.

  1995influential reference
• High variability of nitrosamine metabolism among individuals: Role of cytochromes P450 2A6 and 2E1 in the dealkylation of N‐nitrosodimethylamine and N‐nitrosodiethylamine in mice and humans

  1993cited by this paper
• Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.

  1992cited by this paper
• Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide.

  1992cited by this paper
• Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine.

  1992cited by this paper
• Purification and characterization of human liver microsomal cytochrome P-450 2A6.

  1991cited by this paper
• Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity.

  1990cited by this paper
• The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.

  1990cited by this paper
• Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: implications for the assignment of substrate specificity.

  1989cited by this paper
• Roles of CYP 2 A 6 and CYP 2 B 6 in nicotine C-oxidation by human liver microsomes

  year unknowncited by this paper

• PharmVar GeneFocus: CYP2A6

  2024cites this paper
• Alcohol and Nicotine Use among Adolescents: An Observational Study in a Sicilian Cohort of High School Students

  2022cites this paper
• Environmental Microbiology and Biotechnology: Volume 2: Bioenergy and Environmental Health

  2021cites this paper
• Xenobiotic Metabolic Enzymes: Bioactivation and Antioxidant Defense

  2020cites this paper
• Interactions of Environmental Risk Factors and Genetic Variations: Association with Susceptibility to Cancer

  2020cites this paper
• Pharmacogenomics in and Its Influence on Pharmacokinetics

  2020cites this paper
• Comparison of Salivary Cotinine Levels of Neonates Born to Mothers Exposed to Varying Degrees of Passive Cigarette Smoke

  2020cites this paper
• Enzyme Polymorphisms Affecting Xenobiotic Toxicity

  2020cites this paper
• Structure–activity relationship and in vitro inhibition of human cytochrome CYP2A6 and CYP2A13 by flavonoids

  2020cites this paper
• Associations of CYP2A6 Gene Polymorphism with Smoking Status among Jordanians: Gender-Related Differences.

  2019cites this paper
• Nicotine-N′-Oxidation by Flavin Monooxygenase Enzymes

  2018cites this paper
• Genetic polymorphisms of the drug-metabolizing enzyme cytochrome P450 2A6 in a Tibetan Chinese population.

  2018cites this paper
• How Do You Like Your Science, Wet or Dry? How Two Lab Experiences Influence Student Understanding of Science Concepts and Perceptions of Authentic Scientific Practice

  2017cites this paper
• Inter-Individual Variability of Cytochrome P450 2A6 Activity in Javanese Smokers’ Urine

  2017cites this paper
• Cadmium Nephropathy and Smoking

  2017cites this paper
• Role of pharmacogenetics for the improvement of cancer treatment

  2016cites this paper
• Celery extract inhibits mouse CYP2A5 and human CYP2A6 activities via different mechanisms.

  2016cites this paper
• Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio

  2016cites this paper
• POLYMORPHISM OF CYTOCHROME P 450 2 A 6 ( CYP 2 A 6 * 1 AND CYP 2 A 6 * 4 ) AMONG JAVANESE INDONESIAN SMOKER AND NON SMOKER

  2015influential citation
• Development and Validation of a New Simple Liquid Chromatographic Method for Determination of Coumarin and its 7-Hydroxy Metabolite as a Marker of Cytochrome P450 2A6 in Rats -

  2015cites this paper
• POLYMORPHISM OF CYTOCHROME P450 2A6 (CYP2A6*1 AND CYP2A6*4) AMONG JAVANESE INDONESIAN SMOKER AND NON SMOKER

  2015influential citation
• Antioxidant effects of coumarins include direct radical scavenging, metal chelation and inhibition of ROS-producing enzymes.

  2015cites this paper
• Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers new substrate specificity towards flavonoids

  2015cites this paper
• Plant Pharmacogenomics: From Drug Discovery to Personalized Ethnomedicine

  2015cites this paper
• Combinations of CYP2A6*4 and Glutathione S-Transferases Gene Polymorphisms Modify the Association Between Maternal Secondhand Smoke Exposure During Pregnancy and Small-for-Gestational-Age.

  2015cites this paper
• Iron-Catalyzed Cα-H Oxidation of Tertiary, Aliphatic Amines to Amides under Mild Conditions.

  2015cites this paper
• Influence of CYP2A6*4 genotypes on maternal serum cotinine among Chinese nonsmoking pregnant women.

  2014cites this paper
• Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population

  2014cites this paper
• Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1

  2014cites this paper
• Pharmacogenomics in Drug Metabolizing Enzymes and Transporters

  2013cites this paper
• Cytochrome P450 2A6 deletion polymorphism and risk of lung cancer: a meta-analysis

  2013cites this paper
• Comparisons of CYP2A6 genotype and enzyme activity between Swedes and Koreans.

  2013cites this paper
• Nicotine-induced retardation of chondrogenesis through down-regulation of IGF-1 signaling pathway to inhibit matrix synthesis of growth plate chondrocytes in fetal rats.

  2013cites this paper
• Inter-individual Variability of Coumarin 7-hydroxylation (CYP2A6 activity) in an Iranian Population

  2013cites this paper
• Cytochrome P450 2A isoenzymes in freshly prepared blood lymphocytes isolated from rats and validation as a biomarker for clinical studies in humans

  2013cites this paper
• Metabolism of 7‐ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants

  2013cites this paper
• SALIVARY COTININE-BIOMARKER OF TOBACCO CONSUMPTION IN THE ASSESSMENT OF PASSIVE SMOKING PREVALENCE

  2012cites this paper
• Suszeptibilitätsmarker [Biomonitoring Methods in German language, 2004]

  2012cites this paper
• Genetic Variations in Metabolizing Enzymes

  2012cites this paper
• Pharmacogenetics in Drug Metabolism: Role of Phase I Enzymes

  2012cites this paper
• A Phase II Study of Clinical Outcomes of 3-Week Cycles of Irinotecan and S-1 in Patients with Previously Untreated Metastatic Colorectal Cancer: Influence of the UGT1A1 and CYP2A6 Polymorphisms on Clinical Activity

  2012cites this paper
• Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy.

  2012cites this paper
• Application of the buccal micronucleus cytome assay and analysis of PON1Gln192Arg and CYP2A6*9(−48T>G) polymorphisms in tobacco farmers

  2012cites this paper
• Importance of pharmacogenetic and environmental factors for variation in caffeine disposition: with special emphasis on CYP1A2, CYP2A6, NAT2 and XO

  2012cites this paper
• CYP2A6: genetics, structure, regulation, and function

  2012cites this paper
• ‘Smoking Genes’: A Genetic Association Study

  2011cites this paper
• Antioxidative effect of folate-modified chitosan nanoparticles.

  2011cites this paper
• Genetic variants in urinary bladder cancer: collective power of the “wimp SNPs”

  2011cites this paper
• RISCO OCUPACIONAL EM FUMICULTORES: GENOTOXICIDADE ASSOCIADA À SUSCETIBILIDADE GENÉTICA

  2011cites this paper
• Functional characterization of cytochrome P450 2A6 (CYP2A6) allelic variants CYP2A6*15 , CYP2A6*16 , CYP2A6*21 and CYP2A6*22 *

  2010cites this paper
• Fundamental reaction pathways for cytochrome P450-catalyzed 5'-hydroxylation and N-demethylation of nicotine.

  2010cites this paper
• Xenobiotic Metabolism Genes and Clubfoot

  2010influential citation
• Biomarkers in Wave III of the Add Health Study

  2010cites this paper
• Functional Characterization of Cytochrome P450 2A6 Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22

  2010cites this paper
• Identification et caractérisation du polymorphisme génétique des cytochromes P450 4A11 et 4A22 (CYP4A11 et CYP4A22) et de la glycine N-acyltransférase (GLYAT)

  2010influential citation
• In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population

  2010influential citation
• TATA box polymorphisms in human gene promoters and associated hereditary pathologies

  2009cites this paper
• A case-control study of CYP1A1, GSTT1 and GSTM1 gene polymorphisms, pregnancy smoking and fetal growth restriction.

  2009cites this paper
• Metabolism of Nicotine and the Tobacco Carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone (NNK): Genetic and Phenotypic Variation

  2009cites this paper
• The screening for single nucleotide polymorphisms of CYP3A4 in chronic myelogenous leukemia patients receiving imatinib

  2009cites this paper
• Polymorphism of human cytochrome P450 enzymes and its clinical impact

  2009cites this paper
• A review of smoking behavior and smokers evidence (chemical modification, inducing nicotine metbolism, and individual variations by genotype: dopaminergic function and personality traits)

  2009influential citation
• Structure, function, regulation and polymorphism of human cytochrome P450 2A6.

  2009cites this paper
• QSAR of cytochrome inhibitors

  2009cites this paper
• Phenotypic CYP2A6 variation and the risk of pancreatic cancer.

  2009cites this paper
• Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer

  2009cites this paper
• Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities.

  2009cites this paper
• The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population.

  2009cites this paper
• Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.

  2009cites this paper
• Genetic Polymorphisms in CYP 1 A 1 ( m 1 ) , ( m 2 ) , ( m 4 ) and CYP 2 A 6 and Susceptibility to Hepatocellular Carcinoma in a Malaysian Study Population

  2008cites this paper
• The Biochemistry of Drug Metabolism – An Introduction

  2008cites this paper
• Smoking risk and the likelihood of quitting among African-American female light and heavy smokers.

  2008cites this paper
• The CYP2A6*4 Allele Is Determinant of S‐1 Pharmacokinetics in Japanese Patients With Non‐small‐cell Lung Cancer

  2008cites this paper
• Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme—an in silico approach

  2008cites this paper
• Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo

  2008cites this paper
• Artemisinin and CYP2A6 activity in healthy subjects

  2008influential citation
• Dose–response effect of ferulic acid against nicotine‐induced tissue damage and altered lipid levels in experimental rats: a pathohistological evaluation

  2008cites this paper
• Cytochrome P450 enzymes affected by artemisinin antimalarials-pharmacokinetic and pharmacogenetic aspects

  2008cites this paper
• Tobacco Dependence and Tobacco Dependence Treatment

  2007cites this paper
• Mechanism-Based Inactivation of Cytochrome P450 2A6 by Decursinol Angelate Isolated from Angelica Gigas

  2007cites this paper
• Prediction Methods for Nicotine Clearance Using Cotinine and 3-Hydroxy-Cotinine Spot Saliva Samples II. Model Application

  2007cites this paper
• In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.

  2007cites this paper
• Cytochrome P450: another player in the myocardial infarction game?

  2007cites this paper
• CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

  2006cites this paper
• Effekte von Nikotin unter besonderer Berücksichtigung der Tumorentstehung im Kopf-Hals-Bereich

  2006cites this paper
• Adolescent nicotine metabolism: ethnoracial differences among dependent smokers.

  2006cites this paper
• 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression.

  2006cites this paper
• Smoking cessation program and CYP2A6 polymorphism.

  2006cites this paper
• Pharmacokinetic interactions affecting the antidiabetic repaglinide

  2006cites this paper
• [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].

  2006cites this paper
• Toxikogenetik und Toxikogenomik

  2006cites this paper
• Pharmacogenomics in DME

  2006cites this paper
• Auswirkungen des CYP2A6*2-Polymorphismus auf die individuelle Nikotinkinetik bei Rauchern

  2006influential citation
• A safety assessment of coumarin taking into account species-specificity of toxicokinetics.

  2006cites this paper
• Using pharmacokinetics to predict the effects of pregnancy and maternal–infant transfer of drugs during lactation

  2006cites this paper
• Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6.

  2006cites this paper
• [Effects of nicotine with special consideration given to tumorigenesis in the head and neck region].

  2006cites this paper
• Investments in cancer genomics: who benefits and who decides.

  2006cites this paper
• Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.

  2005cites this paper
• Temperature effect on the functional expression of human cytochromes P450 2A6 and 2E1 inEscherichia coli

  2005cites this paper